NCT06174896

Brief Summary

Our study aimed to compare the manual placement, direct laryngoscopy and video laryngoscopy assisted placement techniques of LMA Proseal, a new generation laryngeal mask (LMA), and to find an effective placement technique that does not allow airway leakage in one go.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 14, 2023

Completed
11 days until next milestone

Study Start

First participant enrolled

October 25, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 18, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 7, 2024

Completed
Last Updated

October 4, 2024

Status Verified

October 1, 2024

Enrollment Period

5 months

First QC Date

October 14, 2023

Last Update Submit

October 2, 2024

Conditions

Keywords

supraglottic airway devicepediatric population

Outcome Measures

Primary Outcomes (1)

  • Oropharyngeal leak pressure

    Oropharyngeal leak pressure (OLP) will be measured by closing the adjustable pressure limiting valve on the anesthesia machine. The fresh gas flow was adjusted to 3 L/min. When the APL (Adjustable pressure limiting) valve was closed and manually ventilated. The leak sound that occurs during ventilation will be auscultated. The first peak airway pressure at which the leak occurs will be recorded as the oropharyngeal leak pressure. After successful insertion, lma proseal location will be evaluated with fiberoptic imaging.

    within 2-3 minutes after laryngeal mask insertion before start of surgery

Secondary Outcomes (7)

  • Blood pressure

    Preoperatively, one minute after the induction, fifth minute and before removed laryngeal mask.

  • İnsertion time

    intraoperative period

  • Number of placement attempts

    intraoperative period

  • Need for optimization maneuvers

    intraoperative period

  • Complications

    intraoperative and postoperative day 1.

  • +2 more secondary outcomes

Study Arms (3)

Group 1

ACTIVE COMPARATOR

Placement with standard technique

Procedure: Group 1

Group 2

ACTIVE COMPARATOR

Placement with direct laryngoscopy

Procedure: Group 2

Group 3

ACTIVE COMPARATOR

Placement with the aid of video laryngoscopy

Procedure: Group 3

Interventions

Group 1PROCEDURE

The LMA Proseal will be inserted directly by hand, without the use of any laryngoscope, as recommended in the instruction manual. The cuff will be gently guided along the hard palate where it is pushed into the hypopharynx and increased resistance is felt, and the cuff will be placed towards the hypopharynx.

Also known as: Standard technique
Group 1
Group 2PROCEDURE

Appropriately sized laryngoscope blade will be used and after the location of the epiglottis is determined, the tongue and epiglottis will be lifted forward. Then, LMA Proseal will be placed at the point where resistance is felt at a level where the proximal edge of the mask can be seen.

Also known as: Placement with direct laryngoscopy
Group 2
Group 3PROCEDURE

After the video laryngoscope is placed with an appropriately sized blade, the location of the epiglottis and vocal cords will be determined and the LMA Proseal will be placed at the point where slight resistance is encountered after the epiglottis is lifted. proximal aspect of LMA

Also known as: Placement with the aid of video laryngoscopy
Group 3

Eligibility Criteria

Age1 Year - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • years old
  • Between 5-40 kg
  • ASA (American Society of Anesthesiologists) physical score I/II
  • Cases undergoing elective surgery lasting less than 90 minutes

You may not qualify if:

  • Patients who are expected to have a difficult airway
  • Those with potential regurgitation risk (severe GER, presence of hiatal hernia)
  • Those who will undergo head and neck surgery, laparoscopic surgery
  • Those who will undergo surgery in the prone position
  • Emergency surgical interventions
  • Those who need muscle relaxants
  • Presence of intraoral abscess, pharyngeal pathology
  • Those who have had an upper or lower respiratory tract infection in the last 4 weeks
  • History of allergy to the drugs to be used
  • Failure of patients and their relatives to give consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ondokuz Mayis University

Samsun, Turkey (Türkiye)

Location

Related Publications (3)

  • Oba S, Turk HS, Isil CT, Erdogan H, Sayin P, Dokucu AI. Comparison of the Supreme and ProSeal laryngeal mask airways in infants: a prospective randomised clinical study. BMC Anesthesiol. 2017 Sep 5;17(1):125. doi: 10.1186/s12871-017-0418-z.

    PMID: 28870163BACKGROUND
  • Shyam T, Selvaraj V. Airway management using LMA-evaluation of three insertional techniques-a prospective randomised study. J Anaesthesiol Clin Pharmacol. 2021 Jan-Mar;37(1):108-113. doi: 10.4103/joacp.JOACP_60_19. Epub 2021 Apr 10.

    PMID: 34103833BACKGROUND
  • Kim GW, Kim JY, Kim SJ, Moon YR, Park EJ, Park SY. Conditions for laryngeal mask airway placement in terms of oropharyngeal leak pressure: a comparison between blind insertion and laryngoscope-guided insertion. BMC Anesthesiol. 2019 Jan 5;19(1):4. doi: 10.1186/s12871-018-0674-6.

    PMID: 30611202BACKGROUND

MeSH Terms

Interventions

Drug Implants

Intervention Hierarchy (Ancestors)

Delayed-Action PreparationsDosage FormsPharmaceutical Preparations

Study Officials

  • Yasemin Burcu Üstün, Prof. Dr

    Ondokuz Mayıs University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Sealed opaque envelopes containing study participation numbers will be used to assign each patient. A researcher not involved in patient follow-up will use the web-based "Research Randomizer" (Urbaniak and Plous 2013) tool to give each participation number to a random group with a 1:1:1 ratio. A nurse not an active investigator in the study will have each participant choose an envelope containing the study participation number. They will inform the anesthetist who will administer the methods which group the patient is in immediately before administration. Researchers, patients, surgeons, and nurses will not be aware of the randomization of groups.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A block randomization list will be created by a doctor who does not participate in patient follow-up using a web-based program, 'Research Randomizer (Urbaniak and Plous 2013)'.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.Dr

Study Record Dates

First Submitted

October 14, 2023

First Posted

December 18, 2023

Study Start

October 25, 2023

Primary Completion

April 1, 2024

Study Completion

May 7, 2024

Last Updated

October 4, 2024

Record last verified: 2024-10

Locations